Caris Life Sciences, Inc. · Healthcare · Biotechnology
Scores & Status Key
AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
Last
$20.12
+$0.88 (+4.57%) 4:00 PM ET
After hours$20.26
+$0.14 (+0.70%) 11:17 PM ET
Prev closePrevC$19.24
OpenOpen$21.21
Day highHigh$21.46
Day lowLow$19.92
VolumeVol4,554,303
Avg volAvgVol2,367,919
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$5.68B
P/E ratio
2.72
FY Revenue
$348.89M
EPS
7.41
Gross Margin
100.00%
Sector
Healthcare
AI report sections
MIXED
CAI
Caris Life Sciences, Inc.
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
+153% (Above avg)
Vol/Avg: 2.53×
RSI
34.32(Weak)
Weak (30–40)
0255075100
MACD momentum
Intraday
-0.01 (Weak)
MACD: -0.03 Signal: -0.02
Short-Term
-0.14 (Weak)
MACD: -1.78 Signal: -1.63
Long-Term
-0.31 (Weak)
MACD: -2.37 Signal: -2.05
Intraday trend score
54.00
LOW54.00HIGH68.00
Latest news
CAI•12 articles•Positive: 1Neutral: 0Negative: 0
PositiveBenzinga• Vandana Singh
Cancer Test Maker Caris Life Sciences Unveils Breakthrough In Early Cancer Detection, Profit Surprise
Caris Life Sciences reported better-than-expected Q4 earnings with 28 cents per share versus consensus loss of 3 cents, and sales jumped 125% year-over-year to $292.89 million. The company unveiled positive interim results from its Achieve 1 study showing superiority of its Caris Detect multi-cancer early detection test compared to traditional methods. Shares surged 20.43% in premarket trading.
Company exceeded earnings expectations with 28 cents EPS vs. consensus loss of 3 cents, achieved 125% sales growth year-over-year, reported significant gross margin improvement of 2,000 basis points, demonstrated positive Adjusted EBITDA of $106.1 million, and unveiled breakthrough interim results for Caris Detect showing superiority over traditional cancer detection methods. Stock price surged 20.43% in premarket trading.
UnknownZacks Investment Research• Zacks Equity Research
Are Investors Undervaluing CAI International (CAI) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CAI
UnknownZacks Investment Research• Zacks Equity Research
Is CAI International (CAI) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CAI
UnknownZacks Investment Research• Zacks Equity Research
Is CAI International (CAI) a Potential Stock for Value Investors?
Is CAI International (CAI) a great pick from the value investor's perspective right now? Read on to know more.
CAI
UnknownZacks Investment Research• Zacks Equity Research
CAI International (CAI) Hits 52-Week High, Can the Run Continue?
CAI International (CAI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CAI
UnknownZacks Investment Research• Zacks Equity Research
Is CAI International (CAI) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CAI
UnknownSeeking Alpha• Asif Suria
Merger Arbitrage Mondays - BAMR Acquires American National Group At A Large Premium
Two rumored deals materialize at very large premiums. In a battle of railroads, Canadian Pacific comes back but gets rejected by Kansas City Southern.
ANATASAXBAMRBANC
UnknownZacks Investment Research• Zacks Equity Research
Is CAI International (CAI) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CAI
UnknownZacks Investment Research• Zacks Equity Research
CAI International (CAI) to Report Q2 Results: Wall Street Expects Earnings Growth
CAI International (CAI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The company has agreed to be acquired in a $2.9 billion deal.
CAIinvesting
UnknownZacks Investment Research• Zacks Equity Research
CAI International (CAI) Enters Overbought Territory
CAI International (CAI) has moved higher as of late, but there could definitely be trouble on the horizon for this company.
CAI
UnknownZacks Investment Research• Zacks Equity Research
Is CAI International (CAI) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CAI
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal